342 related articles for article (PubMed ID: 32281328)
21. Traditional Chinese Medicine in the Treatment of Patients Infected with 2019-New Coronavirus (SARS-CoV-2): A Review and Perspective.
Yang Y; Islam MS; Wang J; Li Y; Chen X
Int J Biol Sci; 2020; 16(10):1708-1717. PubMed ID: 32226288
[TBL] [Abstract][Full Text] [Related]
22. Traditional Chinese Medicine: an effective treatment for 2019 novel coronavirus pneumonia (NCP).
DU HZ; Hou XY; Miao YH; Huang BS; Liu DH
Chin J Nat Med; 2020 Mar; 18(3):206-210. PubMed ID: 32245590
[TBL] [Abstract][Full Text] [Related]
23. Exploring the pathogenesis of depression and potential antidepressants through the integration of reverse network pharmacology, molecular docking, and molecular dynamics.
Lu Z; Gao F; Teng F; Tian X; Guan H; Li J; Wang X; Liang J; Tian Q; Wang J
Medicine (Baltimore); 2023 Nov; 102(44):e35793. PubMed ID: 37932972
[TBL] [Abstract][Full Text] [Related]
24. Repurposing of clinically approved drugs for treatment of coronavirus disease 2019 in a 2019-novel coronavirus-related coronavirus model.
Fan HH; Wang LQ; Liu WL; An XP; Liu ZD; He XQ; Song LH; Tong YG
Chin Med J (Engl); 2020 May; 133(9):1051-1056. PubMed ID: 32149769
[TBL] [Abstract][Full Text] [Related]
25. Identification of active compounds of traditional chinese medicine derived from maxing shigan decoction for COVID-19 treatment: a meta-analysis and in silico study.
Guo X; Lin Y; He F; Jin Y; Chen S; Li T; Wu C; Zhang L; Chen X
Expert Rev Anti Infect Ther; 2023; 21(8):871-889. PubMed ID: 37481738
[TBL] [Abstract][Full Text] [Related]
26. Yidu-toxicity blocking lung decoction ameliorates inflammation in severe pneumonia of SARS-COV-2 patients with Yidu-toxicity blocking lung syndrome by eliminating IL-6 and TNF-a.
Zhao J; Yang X; Wang C; Song S; Cao K; Wei T; Ji Q; Zheng W; Li J; Zhou X; Liu J
Biomed Pharmacother; 2020 Sep; 129():110436. PubMed ID: 32768938
[TBL] [Abstract][Full Text] [Related]
27. Chemical composition and pharmacological mechanism of Qingfei Paidu Decoction and Ma Xing Shi Gan Decoction against Coronavirus Disease 2019 (COVID-19): In silico and experimental study.
Yang R; Liu H; Bai C; Wang Y; Zhang X; Guo R; Wu S; Wang J; Leung E; Chang H; Li P; Liu T; Wang Y
Pharmacol Res; 2020 Jul; 157():104820. PubMed ID: 32360484
[TBL] [Abstract][Full Text] [Related]
28. [Correlations between tanshinones and soil factors of Salviae Miltiorrhizae Radix et Rhizoma from different producing areas].
Dai YY; Yan BB; Yang J; Zhang YL; Zhang JQ; Xiong F; Guo LP
Zhongguo Zhong Yao Za Zhi; 2024 Apr; 49(7):1793-1801. PubMed ID: 38812191
[TBL] [Abstract][Full Text] [Related]
29. [Mechanism of pregnancy-induced thymus involution and regeneration and medication rules of postpartum prescriptions].
Shu YY; Xu X; Zhang ZW; Gao JL
Zhongguo Zhong Yao Za Zhi; 2023 Aug; 48(16):4275-4284. PubMed ID: 37802854
[TBL] [Abstract][Full Text] [Related]
30. [A systematic pharmacological investigation of pharmacologically active ingredients in Toujie Quwen granules for treatment of COVID-19].
Ma S; Zhang X; Cen J; Hong G; Hong S; Ju W
Nan Fang Yi Ke Da Xue Xue Bao; 2020 Aug; 40(8):1072-1080. PubMed ID: 32895172
[TBL] [Abstract][Full Text] [Related]
31. The clinical benefits of Chinese patent medicines against COVID-19 based on current evidence.
Zhang D; Zhang B; Lv JT; Sa RN; Zhang XM; Lin ZJ
Pharmacol Res; 2020 Jul; 157():104882. PubMed ID: 32380051
[TBL] [Abstract][Full Text] [Related]
32. Protection against COVID-19 injury by qingfei paidu decoction via anti-viral, anti-inflammatory activity and metabolic programming.
Chen J; Wang YK; Gao Y; Hu LS; Yang JW; Wang JR; Sun WJ; Liang ZQ; Cao YM; Cao YB
Biomed Pharmacother; 2020 Sep; 129():110281. PubMed ID: 32554251
[TBL] [Abstract][Full Text] [Related]
33. The important role of polysaccharides from a traditional Chinese medicine-Lung Cleansing and Detoxifying Decoction against the COVID-19 pandemic.
Cao P; Wu S; Wu T; Deng Y; Zhang Q; Wang K; Zhang Y
Carbohydr Polym; 2020 Jul; 240():116346. PubMed ID: 32475597
[TBL] [Abstract][Full Text] [Related]
34. Convergent application of traditional Chinese medicine and gut microbiota in ameliorate of cirrhosis: a data mining and Mendelian randomization study.
Zhou C; Wei J; Yu P; Yang J; Liu T; Jia R; Wang S; Sun P; Yang L; Xiao H
Front Cell Infect Microbiol; 2023; 13():1273031. PubMed ID: 38029250
[TBL] [Abstract][Full Text] [Related]
35. Herbal combinations against COVID-19: A network pharmacology, molecular docking and dynamics study.
Song JB; Zhao LQ; Wen HP; Li YP
J Integr Med; 2023 Nov; 21(6):593-604. PubMed ID: 37805293
[TBL] [Abstract][Full Text] [Related]
36. A narrative literature review on traditional medicine options for treatment of corona virus disease 2019 (COVID-19).
Mirzaie A; Halaji M; Dehkordi FS; Ranjbar R; Noorbazargan H
Complement Ther Clin Pract; 2020 Aug; 40():101214. PubMed ID: 32891290
[TBL] [Abstract][Full Text] [Related]
37. Research Progress on Main Symptoms of Novel Coronavirus Pneumonia Improved by Traditional Chinese Medicine.
Luo CH; Ma LL; Liu HM; Liao W; Xu RC; Ci ZM; Lin JZ; Han L; Zhang DK
Front Pharmacol; 2020; 11():556885. PubMed ID: 33013395
[TBL] [Abstract][Full Text] [Related]
38. Natural Product-Based Screening for Lead Compounds Targeting SARS CoV-2 M
Chen J; Zhou X; Fu L; Xu H
Pharmaceuticals (Basel); 2023 May; 16(5):. PubMed ID: 37242550
[TBL] [Abstract][Full Text] [Related]
39. Banxia Xiexin decoction: A review on phytochemical, pharmacological, clinical and pharmacokinetic investigations.
Zhou Z; An R; You L; Liang K; Wang X
Medicine (Baltimore); 2023 Sep; 102(35):e34891. PubMed ID: 37657053
[TBL] [Abstract][Full Text] [Related]
40. The protective role of shenqi compound in type 2 diabetes: A comprehensive investigation of pancreatic β-cell function and mass.
Yang C; Liu H; Xie Z; Yang Q; Du L; Xie C
Biomed Pharmacother; 2023 Oct; 166():115287. PubMed ID: 37572639
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
